239 related articles for article (PubMed ID: 27226640)
1. Activation of Epidermal Growth Factor Receptor/p38/Hypoxia-inducible Factor-1α Is Pivotal for Angiogenesis and Tumorigenesis of Malignantly Transformed Cells Induced by Hexavalent Chromium.
Kim D; Dai J; Park YH; Fai LY; Wang L; Pratheeshkumar P; Son YO; Kondo K; Xu M; Luo J; Shi X; Zhang Z
J Biol Chem; 2016 Jul; 291(31):16271-81. PubMed ID: 27226640
[TBL] [Abstract][Full Text] [Related]
2. Constitutive activation of epidermal growth factor receptor promotes tumorigenesis of Cr(VI)-transformed cells through decreased reactive oxygen species and apoptosis resistance development.
Kim D; Dai J; Fai LY; Yao H; Son YO; Wang L; Pratheeshkumar P; Kondo K; Shi X; Zhang Z
J Biol Chem; 2015 Jan; 290(4):2213-24. PubMed ID: 25477514
[TBL] [Abstract][Full Text] [Related]
3. Repression of miR-143 mediates Cr (VI)-induced tumor angiogenesis via IGF-IR/IRS1/ERK/IL-8 pathway.
He J; Qian X; Carpenter R; Xu Q; Wang L; Qi Y; Wang ZX; Liu LZ; Jiang BH
Toxicol Sci; 2013 Jul; 134(1):26-38. PubMed ID: 23748240
[TBL] [Abstract][Full Text] [Related]
4. Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.
Pratheeshkumar P; Son YO; Divya SP; Roy RV; Hitron JA; Wang L; Kim D; Dai J; Asha P; Zhang Z; Wang Y; Shi X
Toxicol Appl Pharmacol; 2014 Dec; 281(2):230-41. PubMed ID: 25448439
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
Proctor DM; Suh M; Campleman SL; Thompson CM
Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
[TBL] [Abstract][Full Text] [Related]
6. The mineral dust-induced gene,
Zhou H; Geng F; Chen Y; Du J; Zhang X; Liu B; Song D; Hou H; Zhao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760153
[TBL] [Abstract][Full Text] [Related]
7. Suppression of miR-143 contributes to overexpression of IL-6, HIF-1α and NF-κB p65 in Cr(VI)-induced human exposure and tumor growth.
Wang L; Qiu JG; He J; Liu WJ; Ge X; Zhou FM; Huang YX; Jiang BH; Liu LZ
Toxicol Appl Pharmacol; 2019 Sep; 378():114603. PubMed ID: 31152816
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional role of Bcl-2 in malignant transformation and tumorigenesis of Cr(VI)-transformed lung cells.
Medan D; Luanpitpong S; Azad N; Wang L; Jiang BH; Davis ME; Barnett JB; Guo L; Rojanasakul Y
PLoS One; 2012; 7(5):e37045. PubMed ID: 22666341
[TBL] [Abstract][Full Text] [Related]
9. Hexavalent chromium induces malignant transformation of human lung bronchial epithelial cells via ROS-dependent activation of miR-21-PDCD4 signaling.
Pratheeshkumar P; Son YO; Divya SP; Turcios L; Roy RV; Hitron JA; Wang L; Kim D; Dai J; Asha P; Zhang Z; Shi X
Oncotarget; 2016 Aug; 7(32):51193-51210. PubMed ID: 27323401
[TBL] [Abstract][Full Text] [Related]
10. Chronic Hexavalent Chromium Exposure Upregulates the RNA Methyltransferase METTL3 Expression to Promote Cell Transformation, Cancer Stem Cell-Like Property, and Tumorigenesis.
Wang Z; Uddin MB; Xie J; Tao H; Zeidler-Erdely PC; Kondo K; Yang C
Toxicol Sci; 2022 Apr; 187(1):51-61. PubMed ID: 35201342
[TBL] [Abstract][Full Text] [Related]
11. Constitutive Activation of NAD-Dependent Sirtuin 3 Plays an Important Role in Tumorigenesis of Chromium(VI)-Transformed Cells.
Clementino M; Kim D; Zhang Z
Toxicol Sci; 2019 May; 169(1):224-234. PubMed ID: 30715550
[TBL] [Abstract][Full Text] [Related]
12. p38 Signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells.
Gao N; Jiang BH; Leonard SS; Corum L; Zhang Z; Roberts JR; Antonini J; Zheng JZ; Flynn DC; Castranova V; Shi X
J Biol Chem; 2002 Nov; 277(47):45041-8. PubMed ID: 12213806
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of hedgehog-interacting protein (HHIP) contributes to hexavalent chromium-induced malignant transformation of human bronchial epithelial cells.
Li P; Zhang X; Murphy AJ; Costa M; Zhao X; Sun H
Carcinogenesis; 2021 Feb; 42(1):136-147. PubMed ID: 32710611
[TBL] [Abstract][Full Text] [Related]
14. Increased Lipogenesis Is Important for Hexavalent Chromium-Transformed Lung Cells and Xenograft Tumor Growth.
Wise JTF; Kondo K
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069382
[TBL] [Abstract][Full Text] [Related]
15. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways.
Park SH; Kim BR; Lee JH; Park ST; Lee SH; Dong SM; Rho SB
Cell Signal; 2014 Jul; 26(7):1506-13. PubMed ID: 24686084
[TBL] [Abstract][Full Text] [Related]
16. Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis.
Wang PS; Liu Z; Sweef O; Saeed AF; Kluz T; Costa M; Shroyer KR; Kondo K; Wang Z; Yang C
Cancer Lett; 2024 May; 589():216827. PubMed ID: 38527692
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells.
Ding SZ; Yang YX; Li XL; Michelli-Rivera A; Han SY; Wang L; Pratheeshkumar P; Wang X; Lu J; Yin YQ; Budhraja A; Hitron AJ
Toxicol Appl Pharmacol; 2013 May; 269(1):61-71. PubMed ID: 23518002
[TBL] [Abstract][Full Text] [Related]
19. Hexavalent Chromium (Cr(VI)) Down-Regulates Acetylation of Histone H4 at Lysine 16 through Induction of Stressor Protein Nupr1.
Chen D; Kluz T; Fang L; Zhang X; Sun H; Jin C; Costa M
PLoS One; 2016; 11(6):e0157317. PubMed ID: 27285315
[TBL] [Abstract][Full Text] [Related]
20. Protection from Cr(VI)-induced malignant cell transformation and tumorigenesis of Cr(VI)-transformed cells by luteolin through Nrf2 signaling.
Son YO; Pratheeshkumar P; Wang Y; Kim D; Zhang Z; Shi X
Toxicol Appl Pharmacol; 2017 Sep; 331():24-32. PubMed ID: 28416455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
